Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Neuroinflammation
Published in: Journal of Neuroinflammation 1/2016

Open Access 01-12-2016 | Research

Upregulation of neuronal zinc finger protein A20 expression is required for electroacupuncture to attenuate the cerebral inflammatory injury mediated by the nuclear factor-kB signaling pathway in cerebral ischemia/reperfusion rats

Authors: Jian Zhan, Wenyi Qin, Ying Zhang, Jing Jiang, Hongmei Ma, Qiongli Li, Yong Luo

Published in: Journal of Neuroinflammation | Issue 1/2016

Login to get access

Abstract

Background

Zinc finger protein A20 (tumor necrosis factor alpha-induced protein 3) functions as a potent negative feedback inhibitor of the nuclear factor-kB (NF-kB) signaling. It exerts these effects by interrupting the activation of IkB kinase beta (IKKβ), the most critical kinase in upstream of NF-kB, and thereby controlling inflammatory homeostasis. We reported previously that electroacupuncture (EA) could effectively suppress IKKβ activation. However, the mechanism underlying these effects was unclear. Therefore, the current study further explored the effects of EA on A20 expression in rat brain and investigated the possible mechanism of A20 in anti-neuroinflammation mediated by EA using transient middle cerebral artery occlusion (MCAO) rats.

Methods

Rats were treated with EA at the “Baihui (GV20),” “Hegu (L14),” and “Taichong (Liv3)” acupoints once a day starting 2 h after focal cerebral ischemia. The spatiotemporal expression of A20, neurobehavioral scores, infarction volumes, cytokine levels, glial cell activation, and the NF-kB signaling were assessed at the indicated time points. A20 gene interference (overexpression and silencing) was used to investigate the role of A20 in mediating the neuroprotective effects of EA and in regulating the interaction between neuronal and glial cells by suppressing neuronal NF-kB signaling during cerebral ischemia/reperfusion-induced neuroinflammation.

Results

EA treatment increased A20 expression with an earlier peak and longer lasting upregulation. The upregulated A20 protein was predominantly located in neurons in the cortical zone of the ischemia/reperfusion. Furthermore, neuronal A20 cell counts were positively correlated with neurobehavioral scores but negatively correlated with infarct volume, the accumulation of pro-inflammatory cytokines, and glial cell activation. Moreover, the effects of EA on improving the neurological outcome and suppressing neuroinflammation in the brain were reversed by A20 silencing. Finally, A20 silencing also suppressed the ability of EA to inhibit neuronal NF-kB signaling pathway.

Conclusions

Ischemia/reperfusion cortical neurons in MCAO rats are the main cell types that express A20, and there is a correlation between A20 expression and the suppression of neuroinflammation and the resulting neuroprotective effects. EA upregulated neuronal A20 expression, which played an essential role in the anti-inflammatory effects of EA by suppressing the neuronal NF-kB signaling pathway in the brains of MCAO rats.
Literature
1.
Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics—2016 update. Circulation. 2016;133:447–54.CrossRefPubMed
2.
Liu L, Wang D, Wong KS, Wang Y. Stroke and stroke care in China: huge burden, significant workload, and a national priority. Stroke. 2011;42:3651–4.CrossRefPubMed
3.
4.
Luan H, Kan Z, Yong X, Lv C, Jiang W. Rosmarinic acid protects against experimental diabetes with cerebral ischemia: relation to inflammation response. J Neuroinflammation. 2013;10:1–10.CrossRef
5.
Inta I, Paxian S, Maegele I, Zhang W, Pizzi M, Spano P. Bim and Noxa are candidates to mediate the deleterious effect of the NF-kappa B subunit RelA in cerebral ischemia. J Neurosci. 2006;26:12896–903.CrossRefPubMed
6.
Pizzi M, Sarnico I, Boroni F, Benetti A, Benarese M, Spano PF. Inhibition of IkappaBalpha phosphorylation prevents glutamate-induced NF-kappaB activation and neuronal cell death. Acta Neurochir Supplement. 2005;93:59–63.CrossRef
7.
Sarnico I, Lanzillotta A, Benarese M, Alghisi M, Baiguera C, Battistin L, et al. NF-kappaB dimers in the regulation of neuronal survival. Int Rev Neurobiol. 2009;85:351–62.CrossRefPubMed
8.
Sarnico I, Lanzillotta A, Boroni F, Benarese M, Alghisi M, Schwaninger M. NF-kappaB p50/RelA and c-Rel-containing dimers: opposite regulators of neuron vulnerability to ischaemia. J Neurochem. 2009;108:475–85.CrossRefPubMed
9.
Sara Anna B, Giulia FT, Daniela U, Mery M, Laura B, Cristina L. Nuclear factor kB-dependent neurite remodeling is mediated by Notch pathway. J Neuro sci. 2011;31:11697–705.
10.
Nijboer CH, Heijnen CJ, Groenendaal F, van Bel F, Kavelaars A. Alternate pathways preserve tumor necrosis factor-alpha production after nuclear factor-kappaB inhibition in neonatal cerebral hypoxia-ischemia. Stroke. 2009;40:3362–8.CrossRefPubMed
11.
12.
Rius J, Guma M, Schachtrup C, Akassoglou K, Zinkernagel AS, Nizet V. NF-kB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α. Nature. 2008;453:807–11.CrossRefPubMedPubMedCentral
13.
Candelario-Jalil E, Yang Y, Rosenberg GA. Diverse roles of matrix metalloproteinase and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia neuroscience. Neurosci. 2009;158:983–94.CrossRef
14.
Vahedi K, Hofmeijer J, Juettler E, Vicaut E, George B, Algra A, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol. 2007;6:215–22.CrossRefPubMed
15.
16.
Dixit VM, Green S, Sarma V, Holzman LB, Wolf FW, O’Rourke K. Tumor necrosis factor-alpha induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin. J Biol Chem. 1990;265:2973–8.PubMed
17.
Opipari Jr AW, Boguski MS, Dixit VM. The A20 cDNA induced by tumor necrosis factor alpha encodes a novel type of zinc finger protein. J Biol Chem. 1990;265:14705–8.PubMed
18.
Verstrepen L, Verhelst K, van Loo G, Carpentier I, Ley SC, Beyaert R. Expression, biological activities and mechanisms of action of A20 (TNFAIP3). Biochem Pharmacol. 2010;80:2009–20.CrossRefPubMed
19.
20.
21.
Wertz IE, O'Rourke KM, Zhou H, Eby M, Aravind L, Seshagiri S, Wu P. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature. 2004;430:694–9.CrossRefPubMed
22.
Wertz IE, Newton K, Seshasayee D, Kusam S, Lam C, Zhang J, Popovych N. Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation. Nature. 2015;528:370–5.CrossRefPubMed
23.
24.
Vereecke L, Beyaert R, van Loo G. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology. Trends Immunol. 2009;30:383–91.CrossRefPubMed
25.
Catrysse L, Vereecke L, Beyaert R, van Loo G. A20 in inflammation and autoimmunity. Trends Immunol. 2014;35:22–31.CrossRefPubMed
26.
Zammit NW, Grey ST. Emerging roles for A20 in islet biology and pathology. Adv Exp Med Biol. 2014;809:141–62.CrossRefPubMed
27.
Vereecke L, Beyaert R, van Loo G. Genetic relationships between A20/TNFAIP3, chronic inflammation and autoimmune disease. Biochem Soc Trans. 2011;39:1086–91.CrossRefPubMed
28.
Parvatiyar K, Harhaj EW. Regulation of inflammatory and antiviral signaling by A20. Microbes Infect. 2011;13:209–15.CrossRefPubMed
29.
Gui J, Chen R, Xu W, Xiong S. Remission of CVB3-induced myocarditis with Astragaloside IV treatment requires A20 (TNFAIP3) up-regulation. J Cell Mol Med. 2015;19:850–64.CrossRefPubMedPubMedCentral
30.
Kunter U, Daniel S, Arvelo MB, Choi J, Shukri T, Patel VI. Combined expression of A1 and A20 achieves optimal protection of renal proximal tubular epithelial cells. Kidney Int. 2005;68:1520–32.CrossRefPubMed
31.
Ramsey HE, Da Silva CG, Longo CR, Csizmadia E, Studer P, Patel VI. A20 protects mice from lethal liver ischemia/reperfusion injury by increasing peroxisome proliferator-activated receptor-alpha expression. Liver Transpl. 2009;15:1613–21.CrossRefPubMedPubMedCentral
32.
Lutz J, le Luong A, Strobl M, Deng M, Huang H, Anton M. The A20 gene protects kidneys from ischaemia/reperfusion injury by suppressing pro-inflammatory activation. J Mol Med. 2008;86:1329–39.CrossRefPubMed
33.
Li HL, Zhuo ML, Wang D, Wang AB, Cai H, Sun LH. Targeted cardiac overexpression of A20 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction. Circulation. 2007;115:1885–94.CrossRefPubMed
34.
Bi BL, Wang HJ, Bian H, Tian ZT. Identification of therapeutic targets of ischemic stroke with DNA microarray. Eur Rev Med Pharmacol Sci. 2015;19:4012–9.PubMed
35.
Mc Guire C, Rahman M, Schwaninger M, Beyaert R, van Loo G. The ubiquitin editing enzyme A20 (TNFAIP3) is upregulated during permanent middle cerebral artery occlusion but does not influence disease outcome. Cell Death Dis. 2013;4:e531.CrossRefPubMedPubMedCentral
36.
Dan H, Fang W, Rui Z, Jie W, Kodithuwakku ND, Lan S. Clematichinenoside protects blood brain barrier against ischemic stroke superimposed on systemic inflammatory challenges through up-regulating A20. Brain Behav Immun. 2016;51:56–69.CrossRef
37.
38.
Wang X, Deckert M, Xuan NT, Nishanth G, Just S, Waisman A. Astrocytic A20 ameliorates experimental autoimmune encephalomyelitis by inhibiting NF-kB and STAT1-dependent chemokine production in astrocytes. Acta Neuropathol. 2013;126:711–24.CrossRef
39.
Miao HS, Yu LY, Hui GZ, Guo LH. Antiapoptotic effect both in vivo and in vitro of A20 gene when transfected into rat hippocampal neurons. Acta Pharmacol Sin. 2005;26:33–8.CrossRefPubMed
40.
Liu AJ, Li JH, Li HQ, Fu DL, Lu L, Bian ZX, et al. Electroacupuncture for acute ischemic stroke: a meta-analysis of randomized controlled trials. Am J Chin Med. 2015;43:1–26.CrossRef
41.
Li Y, Wang Y, Zhang H, Wu P, Huang W. The effect of acupuncture on the motor function and white matter microstructure in ischemic stroke patients. Evid Based Complement Alternat Med. 2015;2015:164792.PubMedPubMedCentral
42.
Ratmansky M, Levy A, Messinger A, Birg A, Front L, Treger I. The effects of acupuncture on cerebral blood flow in post-stroke patients: a randomized controlled trial. J Altern Complement Med. 2016;22:33–7.CrossRefPubMed
43.
Pan S, Zhan X, Su X, Guo L, Lv L, Su B. Proteomic analysis of serum proteins in acute ischemic stroke patients treated with acupuncture. Exp Biol Med (Maywood). 2011;236:325–33.CrossRef
44.
Yang EJ, Jiang JH, Lee SM, Hwang HS, Lee MS, Choi SM. Electroacupuncture reduces neuroinflammatory responses in symptomatic amyotrophic lateral sclerosis model. J Neuroimmunol. 2010;223:84–91.CrossRefPubMed
45.
Kim HW, Kang SY, Yoon SY, Roh DH, Kwon YB, Han HJ, et al. Low-frequency electroacupuncture suppresses zymosan-induced peripheral inflammation via activation of sympathetic post-ganglionic neurons. Brain Res. 2007;1148:69–75.CrossRefPubMed
46.
47.
Gu G, Zhang Z, Wang G, Han F, Han L, Wang K, et al. Effects of electroacupuncture pretreatment on inflammatory response and acute kidney injury in endotoxaemic rats. J Int Med Res. 2011;39:1783–97.CrossRefPubMed
48.
Kavoussi B, Ross BE. The neuroimmune basis of anti-inflammatory acupuncture. Integr Cancer Ther. 2007;6:251–7.CrossRefPubMed
49.
Choi DC, Lee JY, Lim EJ, Baik HH, Oh TH, et al. Inhibition of ROS-induced p38MAPK and ERK activation in microglia by acupuncture relieves neuropathic pain after spinal cord injury in rats. Exp Neurol. 2012;236:268–82.CrossRefPubMed
50.
Fu X, Wang YQ, Wang J, Yu J, Wu GC. Changes in expression of nociceptin/orphanin FQ and its receptor in spinal dorsal horn during electroacupuncture treatment for peripheral inflammatory pain in rats. Peptides. 2007;28:1220–8.CrossRefPubMed
51.
Qin WY, Luo Y, Chen L, Tao T, Li Y, Cai YL. Electroacupuncture could regulate the NF-kappaB signaling pathway to ameliorate the inflammatory injury in focal cerebral ischemia/reperfusion model rats. Evid Based Complement Alternat Med. 2013;2013:924541.PubMedPubMedCentral
52.
Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20:84–91.CrossRefPubMed
53.
Buchan A, Pulsinelli WA. Hypothermia but not the N-methyl-D-aspartate antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemia. J Neurosci. 1990;10:311–6.PubMed
54.
Busto R, Dietrich WD, Globus MY, Valdes I, Scheinberg P, Ginsberg MD. Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. J Cereb Blood Flow Metab. 1987;7:729–38.CrossRefPubMed
55.
Garcia JH, Wagner S, Liu KF, Hu XJ. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke. 1995;26:627–34.CrossRefPubMed
56.
Ashwal S, Tone B, Tian HR, Cole DJ, Pearce WJ. Core and penumbral nitric oxide synthase activity during cerebral ischemia and reperfusion. Stroke. 1998;29:1037–46.CrossRefPubMed
57.
Qiang W, Xingchun G, Lize X, Weilin J, Shaoyang C, Lichao H. Trans-activator of transcription-mediated delivery of NEP1-40 protein into brain has a neuroprotective effect against focal cerebral ischemic injury via inhibition of neuronal apoptosis. Anesthesiology. 2008;108:1071–80.CrossRef
58.
Saito K, Suyama K, Nishida K, Sei Y, Basile AS. Early increases in TNF-alpha, IL-6 and IL-1 beta levels following transient cerebral ischemia in gerbil brain. Neurosci lett. 1996;206:149–52.CrossRefPubMed
59.
Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 1996;19:312–8.CrossRefPubMed
60.
Cinthia F, Francesca A, Edgar M. Astrocytes are active players in cerebral innate immunity. Trends Immunol. 2007;28:138–45.CrossRef
61.
62.
Nowicka D, Rogozinska K, Aleksy M, Witte OW, Skangiel-Kramska J. Spatiotemporal dynamics of astroglial and microglial responses after photothrombotic stroke in the rat brain. Acta Neurobiol Exp (Wars). 2008;68:155–68.
63.
64.
He J, Crews FT. Increased MCP-1 and microglia in various regions of the human alcoholic brain. Exp Neurol. 2008;210:349–58.CrossRefPubMed
65.
Wang Q, Wang F, Li X, Yang Q, Li X, Xu N. Electroacupuncture pretreatment attenuates cerebral ischemic injury through α7 nicotinic acetylcholine receptor-mediated inhibition of high-mobility group box 1 release in rats. J Neuroinflammation. 2012;9:1–13.
66.
Young W, Rappaport ZH, Chalif DJ, Flamm ES. Regional brain sodium, potassium, and water changes in the rat middle cerebral artery occlusion model of ischemia. Stroke. 1987;18:751–9.CrossRefPubMed
67.
Stephenson D, Yin T, Smalstig EB, Hsu MA, Panetta J, Little S. Transcription factor nuclear factor-kappa B is activated in neurons after focal cerebral ischemia. J Cereb Blood Flow Metab. 2000;20:592–603.CrossRefPubMed
68.
Wang L, Zhang X, Liu L, Yang R, Cui L, Li M. Atorvastatin protects rat brains against permanent focal ischemia and downregulates HMGB1, HMGB1 receptors (RAGE and TLR4), NF-kappaB expression. Neurosci lett. 2010;471:152–6.CrossRefPubMed
69.
Garg P, Duncan RS, Kaja S, Koulen P. Intracellular mechanisms of N-acylethanolamine-mediated neuroprotection in a rat model of stroke. Neurosci. 2010;166:252–62.CrossRef
70.
Chen B, Liao WQ, Xu N, Xu H, Wen JY, Yu CA. Adiponectin protects against cerebral ischemia-reperfusion injury through anti-inflammatory action. Brain res. 2009;1273:129–37.CrossRefPubMed
71.
Cho S, Park EM, Febbraio M, Anrather J, Park L, Racchumi G. The class B scavenger receptor CD36 mediates free radical production and tissue injury in cerebral ischemia. J Neurosci. 2005;25:2504–12.CrossRefPubMed
72.
Kunz A, Abe T, Hochrainer K, Shimamura M, Anrather J, Racchumi G. Nuclear factor-kappaB activation and postischemic inflammation are suppressed in CD36-null mice after middle cerebral artery occlusion. J Neurosci. 2008;28:1649–58.CrossRefPubMedPubMedCentral
73.
Wang G, Guo Q, Hossain M, Fazio V, Zeynalov E, Janigro D. Bone marrow-derived cells are the major source of MMP-9 contributing to blood–brain barrier dysfunction and infarct formation after ischemic stroke in mice. Brain res. 2009;1294:183–92.CrossRefPubMedPubMedCentral
74.
Wang Q, van Hoecke M, Tang XN, Lee H, Zheng Z, Swanson RA. Pyruvate protects against experimental stroke via an anti-inflammatory mechanism. Neurobiol Dis. 2009;36:223–31.CrossRefPubMedPubMedCentral
75.
76.
Pranski EL, Van Sanford CD, Dalal NV, Orr AL, Dipan K, et al. Comparative distribution of protein components of the A20 ubiquitin-editing complex in normal human brain. Neurosci lett. 2012;520:104–9.CrossRefPubMedPubMedCentral
77.
Dvoriantchikova G, Barakat D, Brambilla R, Agudelo C, Hernandez E, Bethea JR. Inactivation of astroglial NF-kappa B promotes survival of retinal neurons following ischemic injury. Eur J Neurosci. 2009;30:175–85.CrossRefPubMedPubMedCentral
78.
Gao S, Mo J, Chen L, Wang Y, Mao X, Shi Y, et al. Astrocyte GGTI-mediated Rac1 prenylation upregulates NF-kappaB expression and promotes neuronal apoptosis following hypoxia/ischemia. Neuropharmacology. 2016;103:44–56.CrossRefPubMed
79.
Michelle L, Block LZ, Jau-Shyong H. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci. 2007;8:57–69.CrossRef
80.
Kaushal V, Schlichter LC. Mechanisms of microglia-mediated neurotoxicity in a new model of the stroke penumbra. J Neurosci. 2008;28:2221–30.CrossRefPubMed
81.
Bhakar AL, Tannis LL, Zeindler C, Russo MP, Jobin C, Park DS. Constitutive nuclear factor-kappa B activity is required for central neuron survival. J Neurosci. 2002;22:8466–75.PubMed
82.
Zhang W, Potrovita I, Tarabin V, Herrmann O, Beer V, Weih F. Neuronal activation of NF-kappaB contributes to cell death in cerebral ischemia. J Cereb Blood Flow Metab. 2005;25:30–40.CrossRefPubMed
83.
Herrmann O, Baumann B, de Lorenzi R, Muhammad S, Zhang W, Kleesiek J. IKK mediates ischemia-induced neuronal death. Nat Med. 2005;11:1322–9.CrossRefPubMed
84.
Ingrassia R, Lanzillotta A, Sarnico I, Benarese M, Blasi F, Borgese L. 1B/(−)IRE DMT1 expression during brain ischemia contributes to cell death mediated by NF-kB/RelA acetylation at Lys310. Plos One. 2012;7:38019.CrossRef
85.
Crack PJ, Taylor JM, Ali U, Mansell A, Hertzog PJ. Potential contribution of NF-kB in neuronal cell death in the glutathione peroxidase-1 knockout mouse in response to ischemia-reperfusion injury. Stroke. 2006;37:1533–8.CrossRefPubMed
Metadata
Title
Upregulation of neuronal zinc finger protein A20 expression is required for electroacupuncture to attenuate the cerebral inflammatory injury mediated by the nuclear factor-kB signaling pathway in cerebral ischemia/reperfusion rats
Authors
Jian Zhan
Wenyi Qin
Ying Zhang
Jing Jiang
Hongmei Ma
Qiongli Li
Yong Luo
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Journal of Neuroinflammation / Issue 1/2016
Electronic ISSN: 1742-2094
DOI
https://doi.org/10.1186/s12974-016-0731-3

Other articles of this Issue 1/2016

Journal of Neuroinflammation 1/2016 Go to the issue

Research

Interferon gamma protects neonatal neural stem/progenitor cells during measles virus infection of the brain

Research

Complement is activated in progressive multiple sclerosis cortical grey matter lesions

Research

Suppression of LPS-induced tau hyperphosphorylation by serum amyloid A

Research

Differential expression of P2X7 receptor and IL-1β in nociceptive and neuropathic pain

Research

Inhibition of myeloperoxidase oxidant production by N-acetyl lysyltyrosylcysteine amide reduces brain damage in a murine model of stroke

Short report

Reduced levels of alpha-1-antitrypsin in cerebrospinal fluid of amyotrophic lateral sclerosis patients: a novel approach for a potential treatment